시장보고서

상품코드

1405777

신장 및 비뇨기 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Nephrology And Urology Devices Market Size, Share & Trends Analysis Report By Product (Ureteral Catheters, PCN Catheters, Urology Guidewires), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

발행일: 2023년 12월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신장 및 비뇨기 기기 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 전 세계 신장 및 비뇨기 기기 시장 규모는 2030년까지 94억 4,000만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 6.9%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

불건강한 생활습관, 흡연과 음주 증가, 불규칙한 식습관은 신장 및 비뇨기과 질환을 유발하는 요인 중 일부입니다. 이로 인해 예측 기간 동안 신장 및 비뇨기과 장치에 대한 수요가 증가할 것으로 예상됩니다. 만성 신장 질환 환자 증가는 산업 성장을 가속할 것으로 예상됩니다. 미국 신장재단 2019에 따르면, 전 세계적으로 만성 신장 질환(CKD)을 앓고 있는 사람은 200만 명 이상으로 추산되며, 매년 수백만 명이 이 질환으로 사망하고 있습니다. 이 숫자는 매년 5-7%의 비율로 계속 증가하고 있습니다.

신장 및 비뇨기 기기 시장은 코로나19 사태로 인해 대부분의 선택적 비뇨기과 수술이 연기되면서 코로나19 환자를 치료하기 위해 의료 환경의 제한된 공간을 확보하기 위해 연기되었기 때문입니다. 예를 들어, 최근 발표된 유럽비뇨기과학회 조사에 따르면, 코로나19 환자를 입원시키기 위해 비뇨기과 병상 가동률이 48.6% 감소했고, 54.2%의 병원에서 임상 활동을 중단했습니다. 그러나 코로나19 환자들은 이후 과민성 방광(OAB)의 새로운 증상이나 악화되는 증상을 보이고 있어 가까운 시일 내에 업계가 성장할 수 있는 좋은 환경을 조성할 수 있을 것으로 기대됩니다.

또한, 비침습적 시술의 채택이 확대되면서 시장 성장을 가속할 것으로 예상됩니다. 콘돔 카테터, 도플러 초음파 비디오 요역학, 방광 내 전립선 돌출증, 음경 커프 등 고통스러운 카테터 삽입을 피하는 데 도움이 되는 비침습적 시술이 시장에 많이 도입되고 있습니다. 이러한 요인으로 인해 신장 및 비뇨기과용 기기 시장 판매가 증가하고 있습니다.

신장 및 비뇨기 기기 시장 보고서의 주요 내용 :

제품별로는 비뇨기과 및 신장 관련 질환의 전 세계 유병률이 높고 주요 기업의 기술적으로 진보된 제품 출시로 인해 2022년 매출 점유율이 27.94%를 넘어섰고, 기타 부문이 시장을 주도했습니다.

PCN 카테터는 소변이 막혔을 때 일시적으로 전환하는 데 사용되기 때문에 다양한 신장 관련 질환에 대한 적용이 증가함에 따라 2023-2030년간 연평균 복합 성장률(CAGR) 7.8%로 가장 높은 성장률을 보일 것으로 예상됩니다.

북미는 2022년 매출 점유율이 32.9%를 넘어서며 시장을 장악했습니다. 주요 기업의 존재, 선진화된 의료 인프라, 의료 시스템에서 공공 자금의 많고 적음 등이 이 지역 시장 성장 요인으로 작용하고 있습니다.

지역별 전망
지역별 신장 및 비뇨기 기기 시장 : 중요 포인트
북미
- 시장 추산·예측, 2018-2030년
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 스웨덴
- 노르웨이
- 덴마크
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출기업의 최근 동향과 영향 분석
시장 진출기업 분류
- Medtronic
- Coloplast
- Boston Scientific Corporation
- Convatec Group plc
- B. Braun SE
- Hollister Incorporated
- Teleflex Inc.
- Baxter
- Fresenius Medical Care AG & Co.
- Asahi Kasei Corporation
- Cook Group
- C. R. Bard Inc.
- Terumo Corporation
- NxStage Medical, Inc.
- Nipro Medical Corporation

LSH 24.01.25

Nephrology And Urology Devices Market Growth & Trends:

The global nephrology and urology devices market size is anticipated to reach USD 9.44 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% from 2023 to 2030. An unhealthy lifestyle, a rise in smoking and alcohol consumption, and dietary irregularities are some of the factors resulting in nephrological and urological disorders. This is anticipated to increase the demand for nephrology and urology devices during the forecast period. Increasing cases of chronic kidney diseases are expected to enhance the industry's growth. According to the National Kidney Foundation 2019, it is estimated there are more than 2 million people around the world that suffer from chronic kidney diseases (CKDs) and millions of people die from this condition every year. This number continues to increase at a rate of 5-7% per year.

The market for nephrology and urology devices was adversely impacted by the COVID-19 pandemic as the majority of elective urological procedures were postponed to free-up limited space in healthcare settings to treat COVID-19 patients. For instance, a recently published survey from the European Association of Urology found that the bed occupancy in the urological departments was reduced by 48.6% in order to hospitalize COVID-19 patients, and clinical activities were halted in 54.2% of the hospitals. However, COVID-19 patients have subsequently shown new or worsening symptoms of overactive bladder (OAB), which might be expected to create a favorable environment for industry growth in the near future.

Moreover, the growing adoption of minimally invasive procedures is expected to fuel market growth. Numerous noninvasive techniques such as condom catheter, Doppler ultrasound video urodynamic, intravesical prostatic protrusion, and penile cuff have been introduced in the market that helps to avoid painful catheterization. These factors have led to an increase in the sale of nephrology and urology devices in the market.

Nephrology And Urology Devices Market Report Highlights:

On the basis of product, the other segment dominated the market in 2022 with a revenue share of over 27.94% owing to the high prevalence of urological and nephrological associated disorders globally and the launch of technologically advanced products by the key players
PCN catheters are expected to expand at the highest CAGR of 7.8% from 2023 to 2030 owing to their increasing application in various kidney-associated medical conditions as they are used for temporary diversion during urinary obstruction
North America dominated the market with a revenue share of over 32.9% in 2022. The presence of prominent players, advanced healthcare infrastructure, and high public funding in the healthcare system are some of the factors responsible for the regional market growth

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End-user
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Nephrology & Urology Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Nephrology & Urology Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Nephrology & Urology Devices Market: Product Estimates & Trend Analysis

4.1. Nephrology and Urology Devices Market: Key Takeaways
4.2. Nephrology and Urology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Ureteral Catheters
- 4.3.1. Ureteral catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. PCN Catheters
- 4.4.1. PCN catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Urinary Stents
- 4.5.1. Urinary stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Stone Basket
- 4.6.1. Stone basket market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Urology Guidewires
- 4.7.1. Urology guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Renal Dilators
- 4.8.1. Renal dilators market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Others
- 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Nephrology & Urology Devices Market: Application Estimates & Trend Analysis

5.1. Nephrology and Urology Devices Market: Key Takeaways
5.2. Nephrology and Urology Devices Market: Application Movement & Market Share Analysis, 2022 & 2030
5.3. Urolithiasis
- 5.3.1. Urolithiasis market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Urological Cancer & BPH
- 5.4.1. Urological cancer & BPH market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Bladder Disorders
- 5.5.1. Bladder Disorders market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Kidney Diseases
- 5.6.1. Kidney Diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nephrology & Urology Devices Market: End-use Estimates & Trend Analysis

6.1. Nephrology and Urology Devices Market: Key Takeaways
6.2. Nephrology and Urology Devices Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Clinics
- 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
- 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Nephrology & Urology Devices Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Nephrology and Urology Devices Market by Region: Key Takeaways
7.3. North America
- 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. China
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Volume, Thousand)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. Saudi Arabia
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
- 8.2.1. Medtronic
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. Coloplast
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Boston Scientific Corporation
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Convatec Group plc
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. B. Braun SE
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. Hollister Incorporated
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. Teleflex Inc.
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. Baxter
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. Fresenius Medical Care AG & Co.
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives
- 8.2.10. Asahi Kasei Corporation
  - 8.2.10.1. Company overview
  - 8.2.10.2. Financial performance
  - 8.2.10.3. Product benchmarking
  - 8.2.10.4. Strategic initiatives
- 8.2.11. Cook Group
  - 8.2.11.1. Company overview
  - 8.2.11.2. Financial performance
  - 8.2.11.3. Product benchmarking
  - 8.2.11.4. Strategic initiatives
- 8.2.12. C. R. Bard Inc.
  - 8.2.12.1. Company overview
  - 8.2.12.2. Financial performance
  - 8.2.12.3. Product benchmarking
  - 8.2.12.4. Strategic initiatives
- 8.2.13. Terumo Corporation
  - 8.2.13.1. Company overview
  - 8.2.13.2. Financial performance
  - 8.2.13.3. Product benchmarking
  - 8.2.13.4. Strategic initiatives
- 8.2.14. NxStage Medical, Inc.
  - 8.2.14.1. Company overview
  - 8.2.14.2. Financial performance
  - 8.2.14.3. Product benchmarking
  - 8.2.14.4. Strategic initiatives
- 8.2.15. Nipro Medical Corporation
  - 8.2.15.1. Company overview
  - 8.2.15.2. Financial performance
  - 8.2.15.3. Product benchmarking
  - 8.2.15.4. Strategic initiatives

신장 및 비뇨기 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Nephrology And Urology Devices Market Size, Share & Trends Analysis Report By Product (Ureteral Catheters, PCN Catheters, Urology Guidewires), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

신장 및 비뇨기 기기 시장 성장 및 동향 :

신장 및 비뇨기 기기 시장 보고서의 주요 내용 :

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 신장 및 비뇨기 기기 시장 변수, 동향 및 범위

제4장 신장 및 비뇨기 기기 시장 : 제품 추정·동향 분석

제5장 신장 및 비뇨기 기기 시장 : 용도 추정·동향 분석

제6장 신장 및 비뇨기 기기 시장 : 최종 용도 추정·동향 분석

제7장 신장 및 비뇨기 기기 시장 : 지역 추정·동향 분석